APA (7th ed.) Citation

Peter E. Silas, Edward N. Zissman, Julie Gardner, Shanjun Helian, Andrew W. Lee, & Heather L. Platt. (2020). A double-blind, randomized, multicenter, controlled study to evaluate the immunogenicity, safety, and tolerability of varicella vaccine (VARIVAX™) passage extension 34 (PE34) process administered concomitantly with measles, mumps, and rubella vaccine (M-M-R™ II). Taylor & Francis Group.

Chicago Style (17th ed.) Citation

Peter E. Silas, Edward N. Zissman, Julie Gardner, Shanjun Helian, Andrew W. Lee, and Heather L. Platt. A Double-blind, Randomized, Multicenter, Controlled Study to Evaluate the Immunogenicity, Safety, and Tolerability of Varicella Vaccine (VARIVAX™) Passage Extension 34 (PE34) Process Administered Concomitantly with Measles, Mumps, and Rubella Vaccine (M-M-R™ II). Taylor & Francis Group, 2020.

MLA (9th ed.) Citation

Peter E. Silas, et al. A Double-blind, Randomized, Multicenter, Controlled Study to Evaluate the Immunogenicity, Safety, and Tolerability of Varicella Vaccine (VARIVAX™) Passage Extension 34 (PE34) Process Administered Concomitantly with Measles, Mumps, and Rubella Vaccine (M-M-R™ II). Taylor & Francis Group, 2020.